skip to content
Read more at: Vital step towards understanding origins of Parkinson's Disease

Vital step towards understanding origins of Parkinson's Disease

Scientists in the CMD have identified the function of a 'mystery protein' that kills healthy brain cells of people with Parkinson's disease.


Read more at: Following the hops of disordered proteins could lead to future treatments of Alzheimer’s disease

Following the hops of disordered proteins could lead to future treatments of Alzheimer’s disease

Demonstrating how to determine the elusive motions of proteins that remain disordered.


Read more at: Revelation of oligomer dynamics provides hope for new Alzheimer's therapies

Revelation of oligomer dynamics provides hope for new Alzheimer's therapies

Revealing for the first time the surprising behaviour of toxic oligomers in the amyloid aggregation process involved in Alzheimer’s and other protein misfolding diseases, thus opening up routes for new therapies against these dreaded killers.


Read more at: Tributes paid to Professor Sir Chris Dobson

Tributes paid to Professor Sir Chris Dobson

Heartfelt tributes are being paid to our distinguished colleague Professor Sir Christopher Dobson - a pioneering researcher in the field of neurodegenerative diseases - who died on 8 September 2019, aged 69.


Read more at: Artwork 'Matter in Grey' illustrates progression of Alzheimer's

Artwork 'Matter in Grey' illustrates progression of Alzheimer's

The artwork created by artist Jacob van der Beugel for the façade of the building illustrates the progression of Alzheimer's and is featured in Trail 1 of the Cambridge Sculpture Trails.


£18 million to help fight Alzheimer's

£18 million to help fight Alzheimer's

Wren Therapeutics, based in the Chemistry of Health Incubator, has received significant funding to help it develop its unique approach to investigating protein misfolding diseases such as Alzheimer's and Parkinson's.


Read more at: Researchers identify a tau homeostasis signature that underlies Alzheimer’s disease

Researchers identify a tau homeostasis signature that underlies Alzheimer’s disease

Researchers have long known that Alzheimer’s is characterized by abnormal clusters of rogue misfolded proteins. A healthy brain has a “quality control system” that effectively keeps them at bay. But problems start when this system goes wrong. 


Read more at: Scientists reveal plan to target the cause of Alzheimer’s disease

Scientists reveal plan to target the cause of Alzheimer’s disease

In a breakthrough, researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease.


Read more at: Chemistry of Health building 'offers hope'

Chemistry of Health building 'offers hope'

"Our scientists, and this building, offer hope," said Vice-Chancellor Stephen J Toope as he officially opened the Chemistry of Health building in September 2018.


Read more at: Moving into our new Chemistry of Health building

Moving into our new Chemistry of Health building

June 2018: researchers have started moving into the Chemistry of Health building, a brand new facility promoting the translation of fundamental research into clinical and commercial applications.


Watch the video

See our building turn from drawing into reality

This time-lapse video captures the Chemistry of Health building's construction from initial dig to final polish - in just three minutes!